Study: NCT03243760

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCI15106 7.5 mg capsule
Description: Orange capsule containing a white to off-white powder, 21.4 mg of CCI15106: Trehalose:Trileucine 35/55/10 weight by weight (w/w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orange capsule containing a white to off-white powder, 21.4 mg of Trehalose:Trileucine 85/15 w/w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orange capsule containing a white to off-white powder, 21.4 mg of Trehalose:Trileucine 85/15 w/w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orange capsule containing a white to off-white powder, 21.4 mg of Trehalose:Trileucine 85/15 w/w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orange capsule containing a white to off-white powder, 21.4 mg of Trehalose:Trileucine 85/15 w/w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orange capsule containing a white to off-white powder, 21.4 mg of Trehalose:Trileucine 85/15 w/w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orange capsule containing a white to off-white powder, 21.4 mg of Trehalose:Trileucine 85/15 w/w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orange capsule containing a white to off-white powder, 21.4 mg of Trehalose:Trileucine 85/15 w/w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orange capsule containing a white to off-white powder, 21.4 mg of Trehalose:Trileucine 85/15 w/w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orange capsule containing a white to off-white powder, 21.4 mg of Trehalose:Trileucine 85/15 w/w

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orange capsule containing a white to off-white powder, 21.4 mg of Trehalose:Trileucine 85/15 w/w